NationalSupply Of Covaxin At Rs 150 Per Dose To Centre Not Sustainable In Long Run: Bharat BiotechBY Outlook Web Bureau
NationalAmid Allegations Of ‘Selling Vaccines’, Punjab Govt Asks Private Hospitals To Return StockBY Outlook Web Bureau
NationalMore Information Required From Bharat Biotech For Emergency Use Listing Of Covaxin: WHOBY Outlook Web Bureau
NationalCovaxin Effective Against UK Strain And Covid Variant Found In India: Bharat BiotechBY Outlook Web Bureau
NationalBharat Biotech Says Can’t Give Additional Covaxin Doses to Delhi: Manish SisodiaBY Outlook Web Bureau
NationalCovaxin Is 78% Effective Against Mild To Severe Covid-19 Infections: Bharat BiotechBY Outlook Web Bureau
NationalBharat Biotech To Ramp Up Manufacturing Capacity, To Produce 700 Mn Doses Of Covaxin AnnuallyBY Outlook Web Bureau
NationalCovaxin Shows 81% Efficacy In Phase 3 Trials, Also Works Against Virus Variants: Bharat BiotechBY Outlook Web Bureau
NationalPM Modi, All CMs Likely To Get Covid Vaccine Shots In 2nd Phase Of Vaccination DriveBY Outlook Web Bureau
NationalDespite Being Based In Hyderabad, Bharat Biotech Yet To Dispatch Covaxin Shots To Telangana GovtBY Outlook Web Bureau
NationalVaccination Not A Business Opportunity: Congress Urges Transparency, Claims Govt Is Paying More VaccinesBY Outlook Web Bureau
NationalThe Covaxin Conundrum: Has India’s Drug Regulator Wrongly Invoked The Emergency Use Law?BY Jeevan Prakash Sharma
NationalAfter Serum Institute, Bharat Biotech Rolls Out Covaxin Ahead Of Inoculation DriveBY Outlook Web Bureau
NationalBhopal: Volunteer Dies 10 Days After Taking Bharat Biotech's Covaxin, Spurs ControversyBY Outlook Web Bureau